Christian Rommel

Insider Reports History

Location
Boston, MA
Signature
/s/ Elizabeth Ryland Waldinger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christian Rommel:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13,000 05 Jun 2025 Direct

Insider Reports Filed by Christian Rommel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRSP CRISPR Therapeutics AG 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:30
CRSP CRISPR Therapeutics AG 30 May 2024 1 $0 4 Director 31 May 2024, 16:15
CRSP CRISPR Therapeutics AG 30 May 2024 0 $0 3 Director 30 May 2024, 16:26